{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T21:25:08Z","timestamp":1648589108131},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.transproceed.2018.02.124","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T15:33:06Z","timestamp":1521387186000},"page":"1889-1891","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of Cervical Infection With Human Papillomavirus of High Oncogenic Potential in Immunosuppressed Women on Renal Replacement Therapy With and Without Mammalian Target of Rapamycin Inhibitors"],"prefix":"10.1016","volume":"50","author":[{"given":"N.","family":"Mazanowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Szpota\u0144ska-Sikorska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Madej","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Pazik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Wielgo\u015b","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Pietrzak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.transproceed.2018.02.124_bib1","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.296.23.2823","article-title":"Cancer incidence before and after kidney transplantation","volume":"296","author":"Vajdic","year":"2006","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.transproceed.2018.02.124_bib2","first-page":"101","article-title":"The risk of ano-genital malignancies in dialysis and transplant patients","volume":"41","author":"Fairley","year":"1994","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1016\/j.transproceed.2018.02.124_bib3","doi-asserted-by":"crossref","first-page":"604","DOI":"10.2215\/CJN.03931106","article-title":"Screening, diagnosis, and treatment of cancer in long-term dialysis patients","volume":"2","author":"Holley","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl. 3","key":"10.1016\/j.transproceed.2018.02.124_bib4","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.transproceed.2018.02.124_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00002018-200023020-00002","article-title":"Post-transplant malignancy: the role of immunosuppression","volume":"23","author":"Penn","year":"2000","journal-title":"Drug Saf"},{"issue":"12","key":"10.1016\/j.transproceed.2018.02.124_bib6","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1097\/01.TP.0000120181.89206.54","article-title":"Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation","volume":"77","author":"Guba","year":"2004","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.transproceed.2018.02.124_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/dat.20530","article-title":"The role of mTOR inhibition in renal transplant immune suppression","volume":"40","author":"Patel","year":"2011","journal-title":"Dial Transplant"},{"issue":"Suppl. 1","key":"10.1016\/j.transproceed.2018.02.124_bib8","article-title":"Optimising the use of mTOR inhibitors in renal transplantation","volume":"2","author":"Russ","year":"2013","journal-title":"Transplant Res"},{"issue":"5","key":"10.1016\/j.transproceed.2018.02.124_bib9","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1128\/JVI.02319-12","article-title":"Cellular entry of human papillomavirus type 16 involves activation of the phosphatidylinositol 3-kinase\/Akt\/mTOR pathway and inhibition of autophagy","volume":"87","author":"Surviladze","year":"2013","journal-title":"J\u00a0Virol"},{"issue":"18","key":"10.1016\/j.transproceed.2018.02.124_bib10","doi-asserted-by":"crossref","first-page":"9398","DOI":"10.1128\/JVI.00974-10","article-title":"The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis","volume":"84","author":"Spangle","year":"2010","journal-title":"J\u00a0Virol"},{"issue":"9","key":"10.1016\/j.transproceed.2018.02.124_bib11","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1158\/1078-0432.CCR-11-2824","article-title":"mTOR as a molecular target in HPV-associated oral and cervical squamous carcinomas","volume":"18","author":"Molinolo","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.transproceed.2018.02.124_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/rmv.1733","article-title":"Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms","volume":"23","author":"Brennan","year":"2013","journal-title":"Rev Med Virol"},{"issue":"6","key":"10.1016\/j.transproceed.2018.02.124_bib13","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1593\/neo.13432","article-title":"Improved clearance during treatment of HPV-positive head and neck cancer through mTOR inhibition","volume":"15","author":"Coppock","year":"2013","journal-title":"Neoplasia"},{"issue":"12","key":"10.1016\/j.transproceed.2018.02.124_bib14","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/lt.20927","article-title":"Conversion to sirolimus: a useful strategy for recalcitrant cutaneous viral warts in liver transplant recipient","volume":"12","author":"Dharancy","year":"2006","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.transproceed.2018.02.124_bib15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ygyno.2014.02.017","article-title":"mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: a critical review","volume":"133","author":"Husseinzadeh","year":"2014","journal-title":"Gynecol Oncol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518303117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518303117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T07:18:09Z","timestamp":1532675889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134518303117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0041134518303117"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.02.124","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of Cervical Infection With Human Papillomavirus of High Oncogenic Potential in Immunosuppressed Women on Renal Replacement Therapy With and Without Mammalian Target of Rapamycin Inhibitors","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.02.124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}